BTIG Upgrades Neogenomics (NEO) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/28/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
NeoGenomics (NEO) Tops Q3 EPS by 1c; Boosts FY16 EPS Outlook
October 26, 2016 8:42 AM EDTNeoGenomics (NASDAQ: NEO) reported Q3 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $60.8 million versus the consensus estimate of $61 million.
GUIDANCE:
NeoGenomics sees FY2016 EPS of $0.14-$0.16, versus prior guidance of $0.08-$0.13 and the... More
